ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 723732 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 723732; 2) Community: the network communities that were significantly associated with the response to NSC 723732; 3) Molecule: the relationships between components within communities and NSC 723732; 4) MDR: the compounds that were significantly associated with the NSC 723732.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.27519356
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0385613993886001 0.085223638
NSC 244404 Null 0.0385613993886001 0.27600621
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0385613993886001 0.094979709
NSC 30915 Null 0.0385613993886001 0.36052501
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.34368889
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.39123974
NSC 39215 Null 0.0385613993886001 0.455465
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.30007149
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0385613993886001 -0.24296576
Total:93  Current:66    [First] [Prev] [Next] [Last]